20.04.2013 Views

S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS

S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS

S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

472<br />

Leitlinie<br />

Comment<br />

There is no special literature on this topic. The recommendations<br />

are based on experience in standard clinical practice.<br />

Recommendation<br />

Principally there are two palliative therapeutic procedures available<br />

for obstruction of the duodenum: an endoscopic stent placement<br />

or a surgical gastroenterostomy. The literature that is available<br />

does not demonstrate a superiority of one of the methods.<br />

Recommendation grade: B, evidence level 3, consensus<br />

Comment<br />

The data published are mainly monocentric case study collections<br />

of patients with duodenal obstruction of different origins<br />

[294, 295]. There are no randomized prospective studies that<br />

compare endoscopic stenting and surgical gastroenterostomy.<br />

Prophylactic gastroenterostomy<br />

Recommendation<br />

According to the current data it seems sensible to perform a prophylactic<br />

gastroenterostomy if irresectability is diagnosed during<br />

surgery.<br />

Recommendation grade: C, evidence level 2b, consensus<br />

Comment<br />

The publication on this topic, a monocentric, prospective, randomized<br />

study shows that a prophylactic gastrojejunostomy<br />

for non-resectable periampullary carcinoma significantly reduces<br />

the future development of pyloric stenosis [145].<br />

Importance of hematopoetic growth factors for locally<br />

advanced pancreatic carcinoma<br />

Recommendation<br />

Granulocyte-stimulating growth factors (G-CSF or GM-CSFs) are<br />

not important for the supportive therapy of locally advanced pancreatic<br />

carcinoma.<br />

Recommendation grade: A, evidence level 1, strong consensus<br />

Comment<br />

Chemotherapy that is so aggressive that the administration of<br />

granulocyte-stimulating growth factors is necessary is not recommended<br />

for palliative treatment of locally advanced or metastatic<br />

pancreatic carcinoma. Refer to the current guidelines of<br />

ASCO on the use of growth factors [296].<br />

Recommendation<br />

Erythrocyte-stimulating growth factors (erythropoietin) can under<br />

certain circumstances play a role.<br />

Recommendation grade: A, evidence level 1, strong consensus<br />

Comment<br />

Also, refer to the current guidelines of ASCO [297] or EORTC<br />

[298].<br />

Adler G et al. <strong>S3</strong>-<strong>Guideline</strong> <strong>“Exocrine</strong> <strong>Pancreatic</strong>… Z Gastroenterol 2008; 46: 449–482<br />

Role of cytoprotectives/radical scavengers during<br />

chemotherapy and/or radiation therapy of pancreatic<br />

carcinoma<br />

Recommendation<br />

Amifostin or other cytoprotectives do not play a role in chemotherapy<br />

and/or radiation therapy of pancreatic carcinoma.<br />

Recommendation grade: A, evidence level 1, strong consensus<br />

Comment<br />

This recommendation follows the meta-analysis of the chemotherapy<br />

and radiation therapy expert panel of the ASCO [299].<br />

Evaluation of pancreatic carcinoma patients’ quality of<br />

life<br />

Recommendation<br />

QLQ-C30 and the related specific pancreas module QLQ-PAN 26 offer<br />

suitable tools for the assessment of quality of life.<br />

Recommendation grade: D, evidence level 5, consensus<br />

Comment<br />

The routine implementation of QLQ-C30 and QLQ-PAN 26 are<br />

only reasonable for clinical studies.<br />

Follow-up<br />

Follow-up program after curative resection<br />

Recommendation<br />

A structured follow-up program cannot be recommended independent<br />

of the pancreatic carcinoma stage.<br />

Recommendation grade: A, evidence level 5, consensus<br />

Comments<br />

There is no scientific proof that structured follow-up with regular<br />

staging examinations leads to an improvement of the survival<br />

of patients with pancreatic cancer.<br />

Medical history and a physical examination are necessary if exocrine<br />

or endocrine insufficiency is suspected. The examination<br />

can be performed regularly by a general practitioner.<br />

Rehabilitation following curative pancreatic carcinoma resection<br />

Recommendation<br />

For individual patients rehabilitation may be useful under certain<br />

conditions. This should be coordinated with the family.<br />

Recommendation grade: D, evidence level 5, consensus<br />

Comment<br />

There is no assessable literature on the role of rehabilitation<br />

after pancreatic carcinoma resection with curative intent.<br />

Acknowledgements<br />

!<br />

We would like to thank the staff of the Clinic for Internal Medicine<br />

I, University of Ulm, T. Locher, R. Lorenz, M. Porzner, I. Rueß,<br />

A. Stein, E. Thanner, and Christian Aslan for the support in preparing<br />

and implementing the consensus conference.<br />

Downloaded by: Thieme Verlagsgruppe. Copyrighted material.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!